Intermittent Fasting and Your Bloodwork: What the 18:6 Protocol Actually Does to Your Biomarkers

The 18:6 intermittent fasting protocol — 18 hours fasting, 6 hours eating — produces measurable improvements in fasting insulin, glucose, triglycerides, and inflammatory markers in most people within 4–8 weeks. Effects on LDL-C vary, and body composition changes depend on total caloric intake. Here's what to expect on your bloodwork and what it means.

Intermittent fasting (IF) has been used in various forms for centuries, but rigorous clinical research on its metabolic effects has accelerated sharply in the past decade. The 18:6 protocol — 18 hours of fasting followed by a 6-hour eating window — is one of the more common patterns used in research and practice. It's more restrictive than the popular 16:8 but less extreme than 24-hour fasting protocols.

Here's what the research shows it does to the biomarkers that matter for longevity.

Fasting Glucose

What the research shows: 18:6 IF consistently reduces fasting glucose in people with elevated baseline levels (prediabetes or early type 2 diabetes). A 2020 study in Cell Metabolism testing an 18-hour fasting window found reductions in fasting glucose of 3–5 mg/dL on average in healthy adults, and larger reductions (8–12 mg/dL) in those starting with elevated glucose.

The mechanism: Extended fasting depletes liver glycogen stores and increases insulin sensitivity via AMPK activation and reduced hepatic glucose output.

Practical implication: If your fasting glucose is in the 90–105 range (normal but not optimal), IF is a meaningful intervention. If you're already below 85, the effect is minimal.

Fasting Insulin and HOMA-IR

What the research shows: This is arguably the strongest effect IF produces. Multiple studies show 20–30% reductions in fasting insulin over 8–12 weeks of consistent IF practice.

HOMA-IR (a calculated measure of insulin resistance using fasting glucose and insulin) decreases proportionally.

Why this matters for longevity: Insulin resistance is a root driver of metabolic syndrome, cardiovascular disease, type 2 diabetes, and accelerated aging. Reducing fasting insulin is among the most impactful metabolic interventions available without medication.

Practical implication: Fasting insulin isn't on most standard panels — you need to request it. A fasting insulin above 10 µIU/mL warrants attention. Optimal is typically below 5 µIU/mL.

Triglycerides

What the research shows: IF reduces triglycerides reliably and often significantly. A meta-analysis of time-restricted eating trials found average triglyceride reductions of 13–20% in overweight adults. Even in lean individuals, reductions of 10–15% are common.

The mechanism: Triglycerides are produced in the liver primarily from excess dietary carbohydrates. Extended fasting reduces hepatic VLDL production and increases triglyceride clearance.

Practical implication: If your triglycerides are above 100 mg/dL, IF is likely to be one of your most effective dietary interventions.

LDL-C and ApoB

What the research shows: This is where results are more variable. LDL-C may increase, decrease, or stay the same depending on diet composition during the eating window. In people losing weight, LDL-C often drops. In people eating very low-carb diets during their eating window, LDL-C may increase.

ApoB (the better marker) tends to decrease modestly in most IF interventions, consistent with reductions in VLDL production. If you're unsure why ApoB matters more than LDL-C, our breakdown of why your LDL number can mislead you explains the distinction.

Practical implication: Don't use IF as a reason to ignore lipid monitoring. Test ApoB before and after 3–4 months to see your individual response.

HDL-C

What the research shows: Modest increases in HDL-C are consistently seen in IF trials — typically 5–10%. The mechanism is improved insulin sensitivity and reduced triglycerides (high triglycerides and low HDL are strongly correlated in metabolic syndrome).

Inflammatory Markers (hsCRP, IL-6)

What the research shows: Several trials show meaningful reductions in hsCRP with IF — typically 20–30% reductions over 8–12 weeks. IL-6 and TNF-alpha also decline in most studies.

The mechanism: Weight loss (even modest), improved insulin sensitivity, and changes in gut microbiome all reduce systemic inflammation. The fasting period itself may activate autophagy and cellular cleanup pathways.

Practical implication: If your hsCRP is above 1.0 mg/L, IF combined with dietary quality improvements is one of the more effective lifestyle interventions for reducing it.

Weight and Body Composition

What the research shows: IF produces weight loss primarily through caloric restriction — people eating in a 6-hour window tend to eat fewer total calories. DEXA data from IF trials shows favorable effects on fat mass with relative preservation of lean mass, particularly when protein intake is maintained.

Important caveat: IF does not create metabolic magic. If you eat the same calories in a 6-hour window as you would in a 12-hour window, you will not lose weight. The benefit of IF for most people is that it naturally reduces total intake by eliminating eating occasions.

What Changes to Test For Before and After

If you're starting IF and want to use bloodwork to evaluate it:

Before (baseline): Fasting glucose, fasting insulin, HbA1c, full lipid panel + ApoB, hsCRP, weight + DEXA if accessible

After 8–12 weeks: Repeat the same panel. This timeframe is sufficient to see meaningful changes in fasting insulin, triglycerides, and hsCRP.

For a guide to interpreting those results once you have them, see how to read your Quest Diagnostics results for longevity.

Who Benefits Most

IF produces the greatest metabolic improvement in people who start with metabolic dysfunction:

• Elevated fasting glucose (90+)
• Elevated fasting insulin (10+)
• High triglycerides (100+)
• High hsCRP (1+)
• Overweight with visceral fat

Lean, metabolically healthy individuals with optimal baseline biomarkers will see smaller changes — which is appropriate. Interventions produce large effects where there's the most room for improvement.

Practical Protocol

Standard 18:6 implementation:

• Eating window: e.g., 12pm–6pm or 1pm–7pm
• Break the fast with a protein-forward meal
• Continue adequate protein through the eating window (1.6–2.2g/kg/day)
• Drink water, black coffee, or plain tea during fasting hours
• Allow 4–6 weeks for the body to adapt before drawing conclusions

FAQ

Will intermittent fasting cause muscle loss?

Not if protein intake is adequate. Multiple studies show lean mass is preserved during IF when protein exceeds 1.6g/kg/day. The concern about IF causing muscle loss is largely based on studies where protein was insufficient.

Can I exercise during fasting?

Yes. Many people train fasted without significant performance reduction, particularly for Zone 2 cardio. High-intensity training fasted may impair performance in some individuals. If you're lifting, consider training near the end of the fast or early in the eating window to optimize muscle protein synthesis.

Is 18:6 better than 16:8 for longevity?

The research difference between 16:8 and 18:6 in metabolic outcomes is not clearly established. More important than the specific window is consistency and diet quality during the eating period. Start with 16:8 and extend to 18:6 only if the shorter window feels sustainable first.